Radiopharmaceuticals and applications;Preparações radiofarmacêuticas e suas aplicações

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 42, Issue 2, 2006, Pages 151-165

  Oliveira, Rita ^a,b   Santos, Delfim ^b   Ferreira, Domingos ^b   Coelho, Pedro ^a,b   Veiga, Francisco ^c  

^a UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Diagnosis; Radionuclide; Radiopharmaceuticals; Therapy

Indexed keywords

CARBON 11; FLUORINE 18; GALLIUM 67; IODINE 123; NITROGEN 13; OXYGEN 15; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TITANIUM;

AUGER ELECTRON SPECTROSCOPY; BLOOD FLOW; ELECTROMAGNETIC RADIATION; GAMMA RADIATION; HUMAN; IONIZING RADIATION; POSITRON; POSITRON EMISSION TOMOGRAPHY; QUALITY CONTROL; RADIOISOTOPE DIAGNOSIS; RADIOISOTOPE THERAPY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TARGET ORGAN;

EID: 33748288060     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-93322006000200002     Document Type: Review

References (17)

1. ANDERSON, C.J.; WELCH, M.J. Radiometal-labeled agents (non-technecium) for diagnostic imaging. Chem. Rev., v. 99, p. 2219-2234, 1999.
2. BALABAN, A.T. Labeled compounds and radiopharmaceuticals aplied in nuclear medicine. John Wiley and Sons Ltd.; 1986.
3. CLARKE, M.J.; SADLER, P.J. Metallopharmaceuticals II-Diagnosis and therapy. New York: Springer, 1999. p. 48-49.
4. DILWORTH, J.R.; PARROT, S.J. The biomedical chemistry of thecnetium and rhenium. Chem. Soc. Rev., v. 27, p. 43-55, 1998
5. ELDER, R.C.; TEPPERMAN, K. Metal-based drugs and imaging agents in Encyclopedia of Inorganic Chemistry, King, R. B. (Eds.). New York: John Wiley and Sons, 1994. p. 2165-2176.
6. EUROPEAN PHARMACOPEIA 5th Ed, Council of Europe. Strasbourg: EDQM, 2005. p. 578
7. FICHNA, J.; JANECKA, A. Synthesis of target-specific radiolabeled peptides for diagnostic imaging. Bioconjugate Chem., v. 14, p. 1-13, 2003.
8. GUO, Z.; SADLER, P.J. Metals in Medicine. Angew. Chem. Int. Ed., v. 38, p. 1512-1531, 1999.
9. HEEG, M.J.; JURISSON, S.S. The role of inorganic chemistry in the development of radiometal agents for cancer therapy. Ass. Chem. Res., v. 32, p. 1053-1060, 1999.
10. JOHANNSEN, B. Tc-99m chemistry and new Tc-99m radiopharmaceuticals. Institute of Bioinorganic and Radiopharmaceutical Chemistry. Rossendorf: Wissenschaftlich-Technische Berichte, 2002. (Annual Report, 2001).
11. JURISSON, S.; BERNING, D.; JIA, W.; MA, D. Coordination compounds in nuclear medicine. Chem. Rev., v. 93, p. 1137-1156, 1993.
12. JURISSON, S.S.; LYDON, J.D. Potencial technecium small molecule, radiopharmaceuticals. Chem. Rev., v. 99, p. 2205-2218, 1999.
13. LIU, S.; EDWARDS, D.S. 99mTc-labeled small peptides as diagnostic radiopharmaceuticals. Chem. Rev., v. 99, p. 2235-2268, 1999.
14. RAKIAS, F.; ZOLLE, I. Handbook of quality control methods of 99mTc-radiopharmaceuticals in Nuclear Medicine; COST B3: WG-1; 1996.
15. SAHA, G.B. Fundamentals of nuclear pharmacy. Springer, 1998. p. 34-170.
16. VALLABHAJOSULA, S. Radiopharmaceuticals in oncology. In: KHALKHALI, I.; MAUBLANT, J.C.; GOLDSMITH, S.J., (Eds.). Nuclear oncology - diagnosis and therapy. Philadelphia: Lippincott Williams and Williams, 2001. p. 31-59.
17. VOLKERT, W.A.; HOFFMAN, T.J. Therapeutic Radiopharmaceuticals. Chem. Rev., v. 99, p. 2269-2292, 1999.